Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | 2 | — | — | — | 2 |
Lung diseases | D008171 | HP_0002088 | J98.4 | — | 2 | — | — | — | 2 |
Obstructive lung diseases | D008173 | HP_0006536 | — | — | 2 | — | — | — | 2 |
Acute kidney injury | D058186 | HP_0001919 | N17 | — | 1 | — | — | — | 1 |
Drug common name | ACUMAPIMOD |
INN | acumapimod |
Description | Acumapimod is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target mitogen-activated protein kinase 14. |
Classification | Small molecule |
Drug class | immunomodulators: mitogen-activated protein (MAP) kinase inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 836683-15-9 |
RxCUI | — |
ChEMBL ID | CHEMBL3545226 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 2F16KW647L (ChemIDplus, GSRS) |